New study tracks High-Risk pregnancies to improve newborn health
NCT ID NCT03755128
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study followed 17 pregnant women and their babies who were at high risk for early onset severe hemolytic disease of the fetus and newborn (EOS-HDFN). The goal was to see how the condition is currently managed and what outcomes occur. No new drugs were tested; instead, researchers observed standard care to gather real-world data.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help doctors better understand how to manage high-risk pregnancies and improve outcomes for affected newborns.
What could go wrong
This is a small observational study with only 17 participants, so findings may not apply to everyone. It does not test any new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY ONSET SEVERE HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN (EOS-HDFN) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier Sainte Justine
Montreal, Quebec, H3T 1C5, Canada
-
Columbia University Medical Center
New York, New York, 10032, United States
-
Hosp Clinic de Barcelona
Barcelona, 08028, Spain
-
Hosp. Univ. San Cecilio
Granada, 18016, Spain
-
Justus-Liebig-Universität Gießen, Kinderherzzentrum
Giessen, 35392, Germany
-
Karolinska Universitetssjukhuset Huddinge
Stockholm, SE-141 86, Sweden
-
Leiden University Medical Center
Leiden, 2333 ZA, Netherlands
-
Liverpool Hospital
Liverpool, 2170, Australia
-
Mount Sinai Hospital
Toronto, Ontario, M5G1X5, Canada
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
-
Queen Elizabeth Hospital
Edgbaston, B15 2TG, United Kingdom
-
The Royal Women's Hospital
Parkville, 3052, Australia
-
The University of British Columbia
Vancouver, British Columbia, V6H 3N1, Canada
-
UPMC
Pittsburgh, Pennsylvania, 15213, United States
-
Universitair Ziekenhuis Leuven
Leuven, 3000, Belgium
-
University College London Hospitals NHSFT
London, WC1E 6DB, United Kingdom
-
University of Cincinnati
Cincinnati, Ohio, 45267, United States
-
University of Utah
Salt Lake City, Utah, 84132, United States